GlassScriptPhysician profile
Steven J Shields
NPI 1336235324
$1,994.59
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $434 · 2021: $438 · 2022: $579.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $520.16 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $493.35 | 2019-2022 | |
| Concordia Pharmaceuticals INC. | $223.45 | 2019 | |
| Gilead Sciences, INC. | $203.62 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $180.78 | 2019-2022 | |
| Braintree Laboratories, INC. | $113.85 | 2019-2022 | |
| Janssen Biotech, INC. | $65.97 | 2019-2022 | |
| Redhill Biopharma INC. | $59.38 | 2020-2022 | |
| Celgene Corporation | $31.18 | 2022 | |
| Romark Laboratories, Lc | $20.28 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $19.38 | 2022 | |
| Merck Sharp & Dohme LLC | $18.51 | 2019 | |
| Pfizer INC. | $15.26 | 2019 | |
| Ferring Pharmaceuticals INC. | $14.88 | 2022 | |
| Qol Medical, LLC | $14.54 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Shields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.